Back

EPAC: a new therapeutic target to control calcium signalling?

28 August 2017 (08:52 - 09:15)
Organised by:
Congress Presentation Part of: Keep calcium signalling under control to prevent heart failure Ion channels and electrophysiology ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Frank Lezoualc'h

Institute of Cardiovascular and Metabolic Diseases, Toulouse (France)

3 More presentations in this session

Presentation thumbnail
Calcium regulation and signal transduction in cardiac fibroblasts.
Doctor S. Lutz (Goettingen, DE)
Slides Video
Presentation thumbnail
IP3 receptor and calcium signalling in heart failure.
Professor L. Roderick (Leuven, BE)
Slides Video
Presentation thumbnail
Gene therapy to target calcium cycling in heart failure.
Doctor R. Hajjar (Boston, US)
Slides Video

Access the full session

Session thumbnail
Keep calcium signalling under control to prevent heart failure

The Event

Event poster

ESC Congress 2017

28 August 2017 08:52 CET
You may be interested in
thumbnail
Congress Presentation
Role of PI3K/Akt and MEK/ERK signalling in Epac-mediated endothelial barrier stabilisation and survival
22 April 2018
thumbnail
Congress Session
The right beat for every heart: personalised care with EHRA-PATHS
30 March 2025
thumbnail
Congress Presentation
Autonomous initiation of pacemaking by L-type Cav1.3 calcium channels in mouse sino-atrial myocytes
23 April 2021
thumbnail
Congress Presentation
Efficacy and safety of various doses of the new dual endothelin receptor antagonist aprocitentan in the treatment of hypertension
31 August 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources